InvestorsHub Logo
Followers 30
Posts 640
Boards Moderated 0
Alias Born 01/17/2022

Re: H2R post# 471021

Wednesday, 05/11/2022 12:11:44 PM

Wednesday, May 11, 2022 12:11:44 PM

Post# of 701788
H2R, interesting that they are not even close.

I am still trying to understand the 3 year 28% survival for the ITT 331 population back in 2018, after virtually all had reached that time cutoff, to now 20% survival of the DCVax treated 232 population, there must be a discoverable reason.

Lykiri? Anyone? What have I missed?

GLTA, much more to come here
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News